Hot Deals:
amol minechem 601.00 (0.17 %) anglo french drugs 930.00 (3.33 %) anugraha valve 280.00 (1.82 %) apl metals 40.00 (-2.44 %) apollo fashion 107.00 (1.90 %) archit nuwood 500.00 arkfin investments 50.00 arohan 202.00 (1.00 %) assam carbon 265.00 (1.92 %) avalokiteshvar 242.00 (0.83 %) axles india 610.00 (1.67 %) balmer lawrie 202.00 (1.00 %) bharat hotels 345.00 (1.47 %) bima mandi 235.00 (-2.08 %) bira 555.00 (-0.89 %) boat 1,380.00 (-1.43 %) c & s electric 840.00 (-1.18 %) cable corporation 13.00 (-0.76 %) capgemini 11,900.00 (0.85 %) care health 186.00 (-1.59 %) carrier aircon 545.00 (-0.91 %) cial 326.00 (0.31 %) csk 170.00 (-1.16 %) dalmia refract 260.00 (1.96 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 440.00 (3.53 %) electronica plastic 2,100.00 (-0.99 %) elgi ultra 400.00 elofic 2,100.00 (2.44 %) esl steel 46.00 (1.10 %) fincare business 86.00 (3.61 %) fincare sfbl 205.00 (1.49 %) fino paytech 133.00 (-1.48 %) flipkart india 231,001.00 (0.00 %) frick india 15,600.00 (-0.95 %) gkn driveline 1,325.00 (-0.38 %) godavari bio 71.00 (1.43 %) goodluck defence 235.00 (2.17 %) group pharma 300.00 gynofem healthcare 63.00 (-3.08 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,120.00 (-0.88 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,300.00 (-1.74 %) hella india 910.00 (1.11 %) hero fincorp 1,990.00 (-0.50 %) hexaware 720.00 (-2.70 %) hicks 1,450.00 (2.11 %) hira ferro 180.00 (2.86 %) honeywell electrical 6,200.00 (1.64 %) ikf finance 312.00 (0.65 %) incred financial 10.00 (1.01 %) incred holdings 165.00 (-1.79 %) india carbon 1,135.00 (-1.30 %) india exposition 121.00 (0.83 %) indian potash 3,250.00 (1.56 %) indian seamless 175.00 (2.94 %) indo alusys 25.75 (-0.96 %) indofil 1,030.00 (0.49 %) infinite computer 405.00 (1.25 %) inkel 29.00 (-3.33 %) jana small finance bank 75.00 kel 610.00 (-2.40 %) kial 126.00 (-1.56 %) klm axiva 15.75 (1.61 %) kurlon limited 1,255.00 (0.40 %) lava 49.00 (-2.00 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 3,050.00 (0.66 %) martin & harris 975.00 (-1.52 %) matrix gas 950.00 (-1.04 %) merino 3,350.00 (1.52 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 410.00 (-2.38 %) mobikwik 595.00 (-0.34 %) mohan meakin 2,150.00 (2.38 %) mohfl 13.60 (-0.73 %) msei 1.15 (-0.86 %) msil 36.00 (2.86 %) nayara energy 595.00 (-0.83 %) nayara energy ncd 315.00 (3.28 %) ncdex 220.00 (-0.90 %) ncl buildtek 310.00 (3.33 %) ncl holdings 92.00 (1.10 %) northern arc 400.00 nsdl 825.00 (1.85 %) nse 5,700.00 (1.79 %) orbis financial 340.00 (0.29 %) oswal minerals 60.10 (-1.48 %) otis 3,700.00 (-0.67 %) oyo 43.50 (-1.14 %) panasonic appliances 262.00 (0.77 %) paymate india 520.00 (-0.95 %) pharmeasy 8.50 (-2.30 %) pharmed limited 480.00 (2.13 %) philips domestic 720.00 (-1.37 %) philips india 910.00 (-1.09 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 255.00 (-1.92 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 505.00 (1.00 %) resins plastics 475.00 (3.26 %) ring plus aqua 530.00 (0.95 %) rrl 1,275.00 (2.00 %) rrp s4e innovation 345.00 (-1.43 %) sab miller 490.00 (2.94 %) sbi amc 2,150.00 (0.94 %) sbi general insurance 620.00 (3.33 %) scottish assam 480.00 (2.13 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,330.00 (-0.75 %) smile microfinance 55.00 (1.85 %) sterlite power 748.00 (-0.27 %) studds 915.00 (-1.08 %) svsml 315.00 (2.94 %) swiggy 355.00 (1.43 %) t stanes 810.00 (1.25 %) tata capital 1,040.00 (-0.95 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,300.00 (1.96 %) urban tots 92.00 (2.22 %) utkarsh coreinvest 310.00 (3.33 %) vadilal dairy 10.00 vikram solar 285.00 (-1.72 %) vivriti capital 1,150.00 (-0.86 %) waree energies 2,150.00 (-0.46 %)
×

Lakeshore Hospital Annual Reports, Balance Sheet and Financials

Lakeshore Hospital And Research Centre Ltd (VPS Lakeshore) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
Lakeshore Hospital And Research Centre Ltd

Lakeshore Hospital And Research Centre Limited Balance Sheet (Rs. In Lakhs)

PARTICULARS  31 March 2023  31 March 2022
ASSETS    
Non-current assets    
Property, Plant and Equipment 32,764.38 34,051.02
Capital work-in-progress 567.26 15.29
Other Intangible assets 44.09 52.97
Right-of-use assets 423.4 479.82
Financial Assets    
Other financial assets 1,321.66 1,938.63
Non-current tax assets (net) 458.65 592.53
Other non-current assets 155.15 216.47
  35,734.59 37,346.73
Current assets    
Inventories 1,271.85 1,106.15
Financial Assets    
Trade receivables 1,998.89 2,013.45
Cash and cash equivalents 3,663.15 1,162.36
Bank balances other than (ii) above 6,178.19 3,898.73
Loans 5.58 6.64
Other financial assets 986.13 669.99
Other current assets 187.33 190.26
  14,291.12 9,047.58
Total Assets 50,025.71 46,394.31
EQUITY AND LIABILITIES    
Equity :    
Equity Share capital 10,000.00 10,000.00
Other Equity 27,344.92 23,121.22
  37,344.92 33,121.22
Liabilities :    
Non-current liabilities    
Financial Liabilities    
Borrowings 723.56 1,300.95
Lease liabilities 427.46 472.04
Other financial liabilities - 841.83
Provisions 1,102.09 1,070.88
Deferred tax liabilities (Net) 1,980.75 1,619.83
Other non-current liabilities 327.02 333.26
  4,560.88 5,638.79
Current liabilities    
Financial Liabilities    
Borrowings 578.85 578.85
Lease liabilities 54.47 51.5
Trade payables    
Total outstanding dues of micro enterprises and small enterprises 106.11 138.52
Total outstanding dues of creditors other than micro enterprises and small enterprises 3,433.27 3,181.46
Other financial liabilities 3,521.04 3,295.28
Other current liabilities 318.21 295.52
Provisions 107.96 93.17
  8,119.91 7,634.30
Total Equity and Liabilities 50,025.71 46,394.31

 

Lakeshore Hospital And Research Centre Limited Profit & Loss Statement (Rs. In Lakhs)

 

PARTICULARS  31 March 2023  31 March 2022
Income:    
Revenue from operations 41,918.42 35,858.70
Other income 535.62 307.11
Total Income 42,454.04 36,165.81
Expenses:    
Purchase of Medicines & Consumables 11,170.49 10,251.14
Changes in inventories of Medicines & Consumables -165.7 -186.46
Employee benefits expense 6,383.50 6,282.48
Finance costs 211.01 257.3
Depreciation and amortisation expense 2,269.19 2,146.15
Other expenses 14,344.09 11,337.27
Total expenses 34,212.58 30,087.88
Profit before tax 8,241.46 6,077.93
Tax expense:    
Current tax 2,660.93 1,520.99
Tax for earlier years 17.09 7.93
Deferred tax -188.44 260.94
  2,489.58 1,789.86
Profit for the year 5751.88 4288.07
Other comprehensive income    
Items that will not be reclassified to profit or loss    
Remeasurements of post employment benefit obligations -39.76 -187.59
Income tax relating to items that will not be reclassified to profit or loss 11.58 54.63
Total other comprehensive income for the year -28.18 -132.96
Total Comprehensive Income for the year 5,723.70 4,155.11
Earnings per equity share of Rs 10 each:    
Basic (`) 5.75 4.29
Diluted (`) 5.75 4.29

 

Lakeshore Hospital And Research Centre Limited Consolidated Cash Flow Statement (Rs. In Lakhs)

Particulars  31 March 2023  31 March 2022
Cash flow from operating activites    
Profit before tax 8,201.70 5,890.34
Adjustments for :    
Depreciation and amortisation 2,269.19 2,146.15
Interest expense 211.01 257.3
Interest income -416.18 -168.7
Net (Profit)/ Loss on sale/write off of Property Plant and Equipment 67.08 237.38
Government grant income -37.44 -23.34
Bad debts and advances written off - -
Provision for doubtful debts 1,098.86 400
Operating cash flow before working capital changes 11,394.22 8,739.13
Movements in working capital :    
(Increase) / decrease in inventories -165.7 -186.46
(Increase) / decrease in trade and other receivables -2,872.51 -5,629.77
Increase / (decrease) in trade and other payables -876.04 1,211.64
  7,479.97 4,134.54
Direct taxes paid net of refunds -1,983.24 -1,015.20
Net cash flows from operating activities (A) 5,496.73 3,119.34
Cashflow from investing activities    
Additions to Property, Plant & Equipment (including capital work in progress) -903.62 -2,645.57
Investment in subsidiaries - -
Sale or withdrawal of property, plant and equipment 9.19 124.33
Interest received 229.75 117.51
Net cash flows from investing activites (B) -664.68 -2,403.73
Cashflow from financing activities    
Proceeds/(Repayment) of Buyers credit/ Term Loan -577.39 -1,841.69
Movement in Short term borrowings (Net) - -
Dividend paid -1,500.67 -497.72
Dividend distribution tax paid - -
Payment of lease liabilities -83.86 -73.81
Interest paid -169.34 -225.84
Net cash flows from financing activities (C) -2,331.26 -2,639.06
Net Increase in Cash & Cash Equivalents (A)+(B)+(C) 2,500.79 -1,923.45
Cash and cash equivalent at the beginning of the Year 1,162.36 3,085.81
Cash and cash equivalent at the end of the Year    
Cash on hand 23.22 30.79
Balance with Banks in current account and deposit account 3,639.93 1,131.57
Cash and cash equivalents 3,663.15 1,162.36
Net increase/(decrease) in Cash and Cash equivalents 2,500.79 -1,923.45

Let 's break down the Cash Flow Statement for the years 2023 and 2022, activity-wise:

1. Cash Flow from Operating Activities:

   - This section begins with the profit before tax, which indicates the company 's earnings before tax deductions.

   - Adjustments are made for non-cash expenses like depreciation and amortization, as well as for interest expenses and income.

   - The net profit or loss from the sale or write-off of Property, Plant, and Equipment is accounted for here, along with any government grant income.

   - After these adjustments, the operating cash flow before working capital changes is calculated.

   - Movements in working capital, such as changes in inventories, receivables, and payables, are then factored in.

   - Direct taxes paid, net of refunds, are deducted to arrive at the net cash flows from operating activities.

 

2. Cash Flow from Investing Activities:

   - This section covers cash flows related to investments in assets and securities.

   - Additions to Property, Plant & Equipment (PPE) are recorded as cash outflows.

   - Any investments made in subsidiaries are also noted.

   - Cash received from the sale or withdrawal of PPE and interest income earned are included.

   - The net cash flows from investing activities are calculated by subtracting cash outflows from cash inflows.

 

3. Cash Flow from Financing Activities:

   - Financing activities involve cash flows related to raising and repaying capital.

   - Proceeds from or repayments of buyers ' credit or term loans are recorded, along with any changes in short-term borrowings.

   - Dividends paid to shareholders and any dividend distribution tax are accounted for as cash outflows.

   - Payments of lease liabilities and interest paid are also included.

   - The net cash flows from financing activities are calculated by summing up cash inflows and outflows.

 

4. Net Increase in Cash & Cash Equivalents:

   - This section calculates the overall change in cash and cash equivalents during the period.

   - It adds the net cash flows from operating, investing, and financing activities to determine the total increase or decrease in cash.

   - The cash and cash equivalents at the beginning of the year are added to this total to find the ending balance of cash and cash equivalents.

 

5. Cash and Cash Equivalents at the Beginning and End of the Year:

   - The cash and cash equivalents at the beginning of the year provide the starting point for the analysis.

   - The ending balance of cash and cash equivalents is calculated by adding the net increase or decrease in cash to the beginning balance.

Financial Ratios of Lakeshore Hospital And Research Centre Limited:

Particulars 2023 2022
(a) Current Ratio 1.76 1.19
(b) Debt-Equity Ratio 0.03 0.06
(c) Debt Service Coverage Ratio 9.83 7.81
(d) Return on Equity Ratio 0.16 0.14
(e) Inventory Turnover Ratio 9.26 9.94
(f) Trade Receivables Turnover Ratio 20.89 18.74
(g) Trade Payables Turnover Ratio 3.26 3.10
(h) Net Capital Turnover Ratio 6.79 25.37
(i) Net Profit Ratio 0.14 0.12

Insights into the financial health and performance of the company in 2023 and 2022:

(a) Current Ratio:

   - The current ratio measures a company 's ability to pay its short-term obligations with its short-term assets.

   - In 2023, the current ratio is 1.76, indicating that the company has 1.76 times more current assets than current liabilities.

   - In 2022, the current ratio was lower at 1.19, suggesting a potential improvement in the company 's liquidity position over the year.

 

(b) Debt-Equity Ratio:

   - The debt-equity ratio compares a company 's total debt to its shareholders ' equity.

   - In 2023, the ratio is 0.03, indicating that the company 's debt is very low compared to its equity.

   - Similarly, in 2022, the ratio was slightly higher at 0.06, suggesting a slight increase in debt relative to equity compared to 2023.

 

(c) Debt Service Coverage Ratio:

   - The debt service coverage ratio measures a company 's ability to cover its debt obligations with its operating income.

   - In 2023, the ratio is 9.83, indicating a strong ability to cover debt payments with operating income.

   - In 2022, the ratio was slightly lower at 7.81, suggesting a relatively weaker coverage of debt payments compared to 2023.

 

(d) Return on Equity Ratio:

   - The return on equity (ROE) ratio measures the profitability of a company in relation to its shareholders ' equity.

   - In 2023, the ROE ratio is 0.16, indicating that the company generated a return of 16% on its shareholders ' equity.

   - In 2022, the ratio was slightly lower at 0.14, suggesting a slight decrease in profitability compared to 2023.

 

(e) Inventory Turnover Ratio:

   - The inventory turnover ratio measures how efficiently a company manages its inventory.

   - In 2023, the ratio is 9.26, indicating that the company turns over its inventory approximately 9.26 times during the year.

   - In 2022, the ratio was slightly higher at 9.94, suggesting a slight decrease in inventory turnover efficiency compared to 2023.

 

(f) Trade Receivables Turnover Ratio:

   - The trade receivables turnover ratio measures how efficiently a company collects its accounts receivable.

   - In 2023, the ratio is 20.89, indicating that the company collects its receivables approximately 20.89 times during the year.

   - In 2022, the ratio was slightly lower at 18.74, suggesting a slight improvement in receivables turnover efficiency compared to 2023.

 

(g) Trade Payables Turnover Ratio:

   - The trade payables turnover ratio measures how efficiently a company manages its accounts payable.

   - In 2023, the ratio is 3.26, indicating that the company pays its suppliers approximately 3.26 times during the year.

   - In 2022, the ratio was slightly lower at 3.10, suggesting a slight decrease in payables turnover efficiency compared to 2023.

 

(h) Net Capital Turnover Ratio:

   - The net capital turnover ratio measures how efficiently a company utilizes its capital to generate revenue.

   - In 2023, the ratio is 6.79, indicating that the company generates revenue of 6.79 times its net capital.

   - In 2022, the ratio was significantly higher at 25.37, suggesting a notable decrease in capital turnover efficiency compared to 2023.

 

(i) Net Profit Ratio:

   - The net profit ratio measures the profitability of a company in relation to its revenue.

   - In 2023, the net profit ratio is 0.14, indicating that the company generates a net profit of 14% of its revenue.

   - In 2022, the ratio was slightly lower at 0.12, suggesting a slight decrease in profitability compared to 2023.

Dividend History of Lakeshore Hospital And Research Centre Limited:

Particulars

2023

Dividend (final + interim) (In Rs.)

1.70

 

 

Annual Report

Lakeshore Hospital Annual Report 2022-23

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha

News Alert